Cargando…
Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
L1CAM promotes cell motility, invasion and metastasis formation in various human cancers and can be considered as a driver of tumor progression. Knowledge about genetic processes leading to the presence of L1CAM in cancers is of considerable importance. Experimentally, L1CAM expression can be achiev...
Autores principales: | Schirmer, Uwe, Doberstein, Kai, Rupp, Anne-Kathleen, Bretz, Niko P., Wuttig, Daniela, Kiefel, Helena, Breunig, Christian, Fiegl, Heidi, Müller-Holzner, Elisabeth, Zeillinger, Robert, Eva, Heidi, Zeimet, Alain G., SÜltmann, Holger, Altevogt, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964221/ https://www.ncbi.nlm.nih.gov/pubmed/24497324 |
Ejemplares similares
-
Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013) -
Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018) -
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
por: Doberstein, Kai, et al.
Publicado: (2014) -
Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
por: Notaro, Sara, et al.
Publicado: (2016) -
L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions
por: Pfeifer, Marco, et al.
Publicado: (2010)